1Mackness, M & Mackness, B (2004) Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radic Biol Med 37, 1317–1323.
2Watson, AD, Berliner, JA, Hama, SY, et al. (1995) Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96, 2882–2891.
3Mackness, MI, Arrol, S, Abbott, C, et al. (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104, 129–135.
4Caliebe, A, Kleindorp, R, Blanche, H, et al. (2010) No or only population-specific effect of PON1 on human longevity: a comprehensive meta-analysis. Ageing Res Rev 9, 238–244.
5Shih, DM, Gu, L, Xia, YR, et al. (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394, 284–287.
6Tward, A, Xia, YR, Wang, XP, et al. (2002) Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106, 484–490.
7Gouedard, C, Barouki, R & Morel, Y (2004) Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24, 5209–5222.
8Boesch-Saadatmandi, C, Pospissil, RT, Graeser, AC, et al. (2009) Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes – role of quercetin metabolism. Int J Mol Sci 10, 4168–4177.
9Boesch-Saadatmandi, C, Niering, J, Minihane, AM, et al. (2010) Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis 211, 110–113.
10Valacchi, G, Rimbach, G, Saliou, C, et al. (2001) Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology 165, 225–234.
11Gaedicke, S, Zhang, X, Schmelzer, C, et al. (2008) Vitamin E dependent microRNA regulation in rat liver. FEBS Lett 582, 3542–3546.
12Wagner, AE, Ernst, I, Iori, R, et al. (2010) Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture. Exp Dermatol 19, 137–144.
13Schiborr, C, Eckert, GP, Rimbach, G, et al. (2010) A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 397, 1917–1925.
14Sikora, E, Scapagnini, G & Barbagallo, M (2010) Curcumin, inflammation, ageing and age-related diseases. Immun Ageing 7, 1.
15Gouedard, C, Barouki, R & Morel, Y (2004) Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler Thromb Vasc Biol 24, 2378–2383.
16Savouret, JF, Antenos, M, Quesne, M, et al. (2001) 7-Ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J Biol Chem 276, 3054–3059.
17Sharma, RA, McLelland, HR, Hill, KA, et al. (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7, 1894–1900.
18Anand, P, Nair, HB, Sung, B, et al. (2010) Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 79, 330–338.